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Abstract 
Engineered skeletal muscle tissue has the potential to aid in valuable research and 
treatment methods for a plethora of musculoskeletal disorders and injuries. While advances have 
been made in the past decade, diseases such as muscular dystrophy lack sufficient predictive 
disease models to facilitate trials of novel medicine. The main technique utilized by scientists 
and researchers are “lab grown” tissues, cultured from mouse or human myoblasts, in-vitro; 
these techniques allow for growth of muscle cells from their proliferative and differentiating 
stages to the formation of mature myofibers. However, these tissues tend to lack vital 
characteristics of native tissue. This project thus focuses on one mechanism which has the 
potential to improve the traits of myoblasts cultured ex-vivo; mechanical stimulation. In the 
absence of a streamlined mechanical stimulation device, the goal of this MQP project was to 
design, prototype, and test such a device.  
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Chapter 1: Introduction 
1.1 Background 
The effects of musculoskeletal disorders and conditions are widespread amongst world 
populations. Musculoskeletal conditions impact up to 1.7 billion people worldwide, being the 
second greatest cause of disability, and the fourth greatest impact on the world’s population 
health overall [1]. Specifically in the United States, musculoskeletal conditions are reported by 1 
of every 2 Americans, and were estimated at costing $213 billion [1]. These conditions and 
disorders cause impairment of performing daily activities, heightened visits to the physician's 
office, and high costs and spending for the individuals and families afflicted with such 
conditions.  
Musculoskeletal conditions are a result of a series of causes such as genetic inheritance, 
age, or injury. One major field of musculoskeletal conditions are sports-related injuries. Skeletal 
muscle injuries account for 55% of all sports related injuries [2]. Injuries to the skeletal muscle 
tissue vary in size and severity. Therefore, the most important factor in finding a treatment is 
understanding the mechanisms of the muscle. Mechanisms such as contraction and flexion.  
Muscle strains and contusions are the most common injury among athletes. A muscle strain 
occurs when a heavy, compressive force is applied to the muscle and a strain occurs when 
excessive tensile force is applied to the muscle. The excessive force leads to the overstraining of 
the myofibers leading to a rupture near the myotendinous junction [2]. Put simply, skeletal 
muscle is composed of two main components: the myofibers and the connective tissue [2]. 
In addition to physical injuries, genetic disorders, such as muscular dystrophy can lead to 
the degradation of muscle tissue. In patients with muscular dystrophy, gene mutations, such as 
missense mutation, interrupt the production of protein that forms healthy muscle tissue [3]. 
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Different types of muscular dystrophy affect different muscle groups and different ages of 
individuals. The most common types of muscle dystrophy are Duchenne and Becker Muscle 
Dystrophy [3]. In the United States, about 1 out of every 7,250 males from age 5-24 were 
diagnosed with DMD or BMD in 2007. Duchenne Muscle Dystrophy is about three times as 
prevalent as Becker Muscle Dystrophy [3]. DMD is earlier onset and diagnosed than BMD but 
both conditions still result in devastating effects on afflicted individuals such as loss of muscle 
mass and function, loss of independence, and premature death. Currently on the market, there is 
no treatment to cure or reverse the damage done by muscular dystrophy.   
Engineered skeletal muscle tissue has potential to further in vitro and in vivo research for 
the treatment of such muscular diseases and injuries. Currently, there is no technology that can 
accurately mimic in-vivo skeletal muscle tissue outside the body. With the lack of a proper 
model, the medical industry is struggling to develop treatments for muscular diseases and 
injuries. Currently on the market, there are 2D in vitro models that utilize mouse cells. These 
models do not accurately represent native tissue. In order to properly represent native tissue, the 
tissue must be able to recapitulate the communication of muscle cells to the extracellular matrix. 
Drugs must go through rigorous testing before being released.  
An in-vitro skeletal muscle sample can help expedite the process of pharmaceutical drug 
testing. Drug testing begins on a large scale. Once the compound shows promise, in-vitro testing 
on cell compounds is typically performed first. Next, testing is performed on an animal disease 
model. After those tests bring a positive result, in-vivo animal disease model is performed [4]. 
In-vitro skeletal muscle tissue model is essential for treating and curing muscle injuries and 
diseases. 
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Mechanical and electrical stimulation is the most effective way to mature in vitro skeletal 
muscle tissue. The current gold standard for in-vitro skeletal muscle tissue engineering is 
designed to mechanically stimulate or electrically stimulate large tissues of muscle. Therefore, 
many of the systems are not capable of high-throughput applications [4]. Two systems on the 
market that are able to do so are MagneTissue Bioreactor and IonOptix C-Pace EP. MagenTissue 
Bioreactor These two systems are made to be used on larger tissue so they are not suited for 
high-throughput applications. Although these are the gold standard they lack the ability to form 
in-vitro muscle tissue that mimics the native tissue. 
1.1 Project Goals 
Researchers currently lack any true in-vitro model of human muscle cell. This has led to a 
gap in the understanding and treatment of the many musculoskeletal disorders that affect a 
portion of the human population. It has also led to a demand and high cost of five billion dollars 
per viable drug in the pharmaceutical drug market. In order to make the necessary advancements 
for the benefit of both the industry and those afflicted individuals it is vital to produce an 
accurate human model.  In order to accomplish this, there are a series of considerations and goals 
which must be made and met. In the design of an in-vitro skeletal muscle tissue system that will 
mimic the traits of normal in-vivo human muscle cells many considerations arise in regards to 
both the technical and physiological aspects.  Some of the major aspects of this model which 
must be considered and met in the design include; dimensions, stage of differentiation, 
maturation, fiber alignment, stimuli, materials, and anchorage. Accurately doing these things will 
allow for the model to succeed i.e the muscle cells will mature and function like those would in 
the human body. Considerations must also be made in regards to the user, federal regulations, as 
well as funding. 
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The first major considerations involve the proper tissue dimensions, fiber alignment, and 
mechanical and electrical stimuli. These aspects directly correlate to the survival of the muscle 
cells. The cells must be accommodated in a properly sized structure, guided to the right 
alignment as they grow to differentiate into muscle fibers, as well as exercising the cells with 
electrical and mechanical apparatus. The muscle cell model needs to mimic the in-vivo 
conditions and functions of native human muscle cells. In-vitro human cells must be cultured to 
differentiate, mature, and linearly align as they would in the human body to ensure they become 
strong and well-formed muscle fibers.  
Another goal which is central to the project’s success is the determination of the optimal 
stage of myoblast differentiation. Some considerations will include the initial seeding of the 
system and the amount of time for the cells to mature. Maturation is extremely important for the 
viability and proliferation of the human muscle cells. It will ensure they mature to the point of 
contractile function which is something human muscle cells do in the body for survival. Optimal 
cell culture conditions are not exact but differing approaches will be analyzed for their effect on 
the differentiation and survival of the muscle cells. 
An additional aspect would be addressing material selection issues. This includes regard 
to the extracellular matrix or scaffold, natural polymers utilized, and other artificial materials 
which may be used. The selected materials and scaffold directly affect the desired cell tissue and 
also affect cell growth, differentiation, and cell organization during formation. For example, the 
use of hydrogels which can be natural or artificial polymers can assist the cells in growth and 
alignment into muscle fibers. Also the use of PDMS as apparatus in contact with the cells will 
allow the cells adhere and grow due to its biocompatibility. Various materials such as the 
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hydrogel or PDMS apparatus, etc. will be explored for their effects on the growth and survival of 
human muscle cells. 
Also considering the methods of applying and measuring contraction to the muscle cells 
is an aim of the model. This aspect will be indicted by the mechanisms of electrical and 
mechanical stimulation. Directly connected to the stimulation and contraction of the human 
muscle cells is their fiber strength. Ensuring that the muscle cells in the model are exercised and 
maintain sufficient strength will allow the model to be representative of the dense, long muscle 
fibers in human skeletal muscle. Some important kinetics of muscle cells include force, 
extension, and relaxation. Ensuring muscle cells are stimulated and exercised in a series of ways 
is important for developing complex muscle cells which can regrow and grow stronger and 
communicate with their surrounding matrix and cells. 
One of the additional but equally important goals is to address the potential requirement 
for supporting the cells. As mentioned briefly before, human muscle cells are anchorage 
dependent for survival. Muscle cell cultures adhere to the surface of their environment. For 
example, muscle cells grown in a petri dish will adhere to the bottom of the plate. When the cells 
contract they will lift off the petri dish and will no longer be viable. For this reason, the muscle 
cells require another source of anchorage to ensure that they mature and differentiate. 
1.2 Project Approach 
 The general approach of the project will cater to the overall need, which is to recapitulate 
the interactions of muscle cells with their extracellular matrix in order to create mature muscle 
tissue for research purposes. Our basic approach to this need is outlined by the following goals: 
design a system to create skeletal muscle in vitro, determine the optimal stage of myoblast 
differentiation, address material selection requirements, as well as maintenance of the mature 
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cells. When we state the phrase “optimal stage of myoblast differentiation”, we are referring to 
the many characteristics that should be exhibited in order to ensure that we have produced 
accurate, mature skeletal muscle tissue, that which can be manipulated for research purposes.  
The optimal stage of myoblast differentiation will be the point at which our engineered tissue 
most closely replicates the properties of native tissue, and depends on multiple factors, including 
choice of culture media, i.e. the composition of our extracellular matrix, as well as our means of 
applying the appropriate stimuli. 
During and after the induction of differentiation, the cell needs to receive nutrients from 
our in-vitro extracellular matrix (ECM). In-vivo, the extracellular matrix consists of collagen, 
other glycoproteins, hyaluronic acid, proteoglycans and elastins, and these molecules are 
responsible for the harboring and delivery of nutrients [5]. The interactions between the ECM 
and cells have a direct influence on their adhesion, migration, growth, differentiation, and finally, 
maintenance. Collagen provides structural support for muscle tissue cells and is crucial for the 
conversion of the myoblasts.  
In order to produce optimal myoblast differentiation the cells must assemble properly. 
Amateur skeletal muscle cells, or myoblasts, need cell-to-cell contact in order to fuse with each 
other and form multinucleated myotubes. This is one known limitation of current in-vitro 
models. Alternately, magnetic field guided-assembly for the design of cell environment will 
produce better cell alignment [6]. 
The cells must be stimulated and contractions measured. Past approaches use flexible 
PDMS posts as anchorage points within a 96-well plate. With this technique, the PDMS posts are 
manipulated to exercise the muscle. One alternate consideration for mobilization of PDMS posts 
is an air-pocket design that can change the volume of a chamber beneath the matrix with the 
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addition or withdrawal of air. Another consideration is the use of magnets for PDMS post 
mobilization. Regarding electrical stimulation, stipulations must be made concerning voltage, 
frequency, amplitude, and pulse width. All of these variables will have a bearing on the resulting 
force production of the mature muscle [7]. 
With these approaches to engineering the human skeletal muscle tissue, it is ultimately 
our hope that this model fosters clinical applications within the pharmaceutical industry as well 
as other research responsible for creating more efficient predictive disease models. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 16 
Chapter 2: Background Research 
2.1 Clinical Significance 
 Human muscles aid in the function and motion of the body as a whole. When there is a 
defect or injury to them, muscles cannot function properly. Muscle disorders, known as 
myopathies, in addition to muscle injuries account for a huge world-wide impact. There is a large 
range of conditions, each with varying causes and symptoms. One of the things that most have in 
common however, is lack of an effective cure. As a whole, musculoskeletal conditions impact 
the quality of life of individuals greatly. 
 To specify, musculoskeletal diseases impact about one out of every two people in the 
United States over the age of 18, with about three out of four individuals over the age of 65 being 
impacted [8]. The rate of these diseases and conditions outweigh that of other significant 
afflictions, such as circulatory and respiratory disorders [8]. One huge impact these afflictions 
have is the rate of visits to the physician’s office, emergency room, and hospital thus amounting 
to large costs on both the individuals and the various medical institutions. Another aspect often 
inflicted by various musculoskeletal disorders is the cost of major diseases or significant injury 
which require long term care for the pain or disability that may affect the individual [8].  
2.1.1 Diseases 
 As mentioned before, there is a wide range of skeletal muscle conditions and disorders. 
Some major types of diseases include metabolic diseases, genetic disorders, inflammatory 
diseases, and neuromuscular disorders. 
 Diagnosis is key in proper management and treatment of the various conditions. Some 
major diagnostic procedures include; history and clinical exams, blood biochemistry, 
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electromyography, muscle biopsy, nuclear magnetic resonance, measuring the muscular cross-
sectional area, functional tests, provocation tests, and studies on protein turnover [9]. Typically, 
one or all of these tests are crucial in comprehensive diagnosis and treatment plans. However, 
there is the drawback that identification of the exact disorder may not be possible [9]. All in all, 
these procedures are necessary at providing relevant information to both the patient and the 
doctors. 
 One of the most prevalent musculoskeletal disorders is muscle dystrophy. The two most 
common types of muscular dystrophies are Duchenne and Becker’s muscular dystrophy, both of 
which the muscle protein dystrophin is either present in lesser amounts or completely lacking 
[11]. The function of the dystrophin protein is to transfer force of the muscle contraction from 
the inside of the muscle cell to the cell membrane and beyond [10]. The protein is extremely long 
because it physically connects the center of the muscle cell to its peripheral anatomy; with the 
central region, known as the rod domain consisting of spectrin repeats [10]. These units are 
extremely important in linking the interior to the exterior of the muscle cell, and in the 
communication between the cell interior and exterior proteins that work together to initiate 
muscle contraction [10]. In these genetic disorders the proteins lose their function as a result of 
fewer spectrin repeats, which contributes to an overall muscle weakness.  
 Both of these dystrophies, amongst the nine other types, are both degenerative and 
genetically inherited that greatly impact the function and health of voluntary muscle groups [10]. 
With Duchenne muscular dystrophy, there is no functional dystrophin produced, and with Becker 
Muscular Dystrophy dystrophin created is partially functional [10]. The direct implication of this 
is muscles in patients with BMD degrading slower and to less of an extent than patients with 
DMD. 
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 Duchenne muscular dystrophy (DMD) and Becker Muscular Dystrophy (BMD) are X-
linked disorders, meaning they can only impact male populations. DMD is most common in 
children, characterized by proximal muscle weakness as well as hypertrophy in early childhood 
development [11]. The affected children are typically wheelchair bound by age 12, and die in 
late teens or early twenties due to cardiorespiratory complications [11]. With BMD, the onset 
occurs in late childhood or adolescence, with a slower and less predictable course in comparison 
to DMD [10]. A general weakness occurs at first specifically in the hip, pelvic, thigh, and 
shoulder areas, followed by calf enlargement and significant cardiovascular issues later down the 
road [10]. Unlike DMD, individuals with BMD can survive into mid-late adulthood. While there 
are various breakthroughs with identifying the protein dystrophin, no treatments have progressed 
to the experimental stage [11]. In addition, there is no real cure for any form of muscular 
dystrophy.  
2.1.2 Injuries 
 Another relevant area in musculoskeletal conditions are injuries to the muscle. While set 
specifications for muscle injuries lack, the main differentiating factor is how the injury occurs 
and to what extent the trauma is [12]. In a broad sense, skeletal muscle injuries are classified as 
either acute/traumatic injuries or chronic/overuse injuries [12]. Acute injuries are characterized 
by a singular traumatic event that results in a large injury to the muscle, while overuse injuries 
are typically exercise induced and result from a build-up over time and tend to be more subtle 
[12]. Acute injuries are easier to diagnose because the link between the cause and symptoms is 
made immediately and easily after injury. Since chronic muscle injuries occur over time, little by 
little, diagnosis is a little more challenging because the link between the symptoms and cause is 
less immediate [12].  
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 Another type of muscle injury are muscle strains, which are contraction induced, and 
result in the tearing of muscle fibers due to an excessive mechanical loads or stresses [12]. There 
are three categories of muscle strains based on the severity of the injury. Grade I, or mild strains, 
are when a limited number or muscle fibers are impacted, there is little to no decrease in strength 
or range of motion, and resultant pains are delayed [12]. Grade II, or moderate muscle strains, 
are defined as injuries that impact nearly half of the muscle fibers, pain and swelling occurs with 
a minor decrease in strength and function [12]. Lastly, grade III, or severe muscle injuries are 
constituted by a complete rupture of the muscle, accompanied by severe swelling and pain and 
loss of function at the musculotendinous junction [12].  
 With these types of injuries the usual repair process follows a typical pattern of two 
phases; destruction phase and repair and remodeling phase [12]. The first phase is constituted by 
the initial trauma and the muscle fiber tear. Necrosis of myofibers occurs due to the injury, 
followed by an inflammatory process and the removal of the necrotic tissue elements by 
specialized cells [12]. In the repair and remodeling phase satellite cells begin the myofiber 
regeneration and a connective tissue scar attempts to fill the gap created by the tear. In the first 
10 days, the scar tissue represents the weakest aspect of the injury, after 10 days the surrounding 
muscle tissue is impacted, while full functional and strength recovery times are hard to quantify 
[12]. The most important processes in recovery include vascularization and nerve to muscle 
contact [12]. 
 As with musculoskeletal diseases, proper diagnosis and treatment are crucial to patient 
recovery from muscle injuries. Diagnosis tools for muscle injuries include a thorough physical 
examination, factoring in patient history of injury, testing functionality, MRI, X-ray, Ultrasound, 
and CT scan [12]. For acute injuries the best treatment includes a short period of immobilization, 
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elevation, compression, elevation, followed by proper mobilization and rehabilitation exercises 
[12]. Traumatic muscle injuries typically require surgical intervention, healing time, and proper 
rehabilitation and conditioning [12]. Overall, with the current treatments for muscle injuries, 
outlook is positive. However, knowledge on the proper function and healing process will only 
aid the recovery process.  
2.2 Skeletal Muscle Anatomy 
This section outlines the structure, function and anatomy of skeletal muscle tissue.  
2.2.1 Structure and Function 
Skeletal muscles are responsible for the movement and structure of the human body. An 
individual skeletal muscle are made up of hundreds of skeletal muscle fibers wrapped in a 
protective connective tissue. Skeletal muscle fibers are made up of a single cylindrical muscle 
cell. The muscle is surrounded by epimysium, a connective tissue sheath. Fascia is located 
outside the epimysium and separates the muscle. The epimysium creates compartments in the 
muscle by projecting inward and dividing the muscle [13]. Those compartments hold a bundle of 
muscle fibers called a fasciculus. The perimysium is a layer of connective tissue that surrounds 
each fasciculus. The endomysium surrounds the each muscle fiber within the fasciculus. The 
connective tissue covering the muscle fibers act as support and protection from contraction 
forces. 
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Figure 1. The structure of skeletal muscle. [13] 
 
The sarcomeres are the contractile backbone of the myofiber. They are cylindrical 
bundles composed of actin, a thin filament about 7 nm, and myosin, a thick filament about 15 
nm. The actin filaments are contained in the I bands and the myosin is found in the A bands. 
Tropomyosin and troponin are also found inside the cylindrical bundles. The Z disc is where the 
sarcomeres end. Figure 3 below shows the H zone, an area where only myosin is observed. The 
M line is the anchor of the myosin filament.    
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Figure 2. Anatomical structure of sarcomeres within myofibrils. [13] 
 
 
Figure 3. Illustration of the H zone. [13] 
 
Skeletal muscle is responsible for many functions of the body, both mechanically and 
metabolically. Mechanically, skeletal muscle controls the conversion of chemical energy to 
mechanical energy. This creates power, helps maintain posture, and generates movement [13]. 
Metabolically, skeletal muscle acts as a storage unit for important substrates for basal energy 
metabolism [13]. This substrates include amino acids and carbohydrates. These aid in the body’s 
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ability to produce heat and maintain core temperature, and the consumption of oxygen during 
physical activities. Amino acids are used by other tissues like skin, brain, and heart for protein 
synthesis [13]. Additionally, muscle mass is important in maintaining health. A lower muscle 
mass decreased the body’s ability to respond to stress and illness.  
2.2.2 Skeletal Muscle Development 
Myogenesis is the formation of skeletal muscle tissue. Myoblasts proliferate in the 
presence of fibroblast growth factor. The fusion of the myoblasts forms muscle fibers [13]. When 
there is no fibroblast growth factor present, the myoblasts stop dividing and form fibronectin in 
the extracellular matrix. Next, the myoblasts align and form myotubes. There are multiple 
muscle-specific genes that are expressed during myogenesis. These include the myocyte 
enhancer factors, serum response factor, and myogenic regulatory factors [13]. The serum 
response factors express the striated alpha-actin genes and regulate myogenesis. The myogenic 
regulatory factors are muscle-specific and include myogenin. Myogenin is involved in the 
alignment of cells during myogenesis.  
2.2.3 Mechanism of Action-Contraction 
 Contraction is the forceful shortening or tightening of a muscle that pulls on a joint as a 
result and causes a movement [14]. Contraction is initiated by the brain sending signals to the 
muscle and as a result the muscle will contract and move. Another big factor in the contraction of 
a muscle is the muscle tone. The tone of a muscle speaks to its readability to contract and the 
tendency of relaxed muscle to resist stretching [14]. A muscle with good tone will hold its shape 
and elastic properties and respond promptly to signals of contraction. Both contraction and tone 
of muscles are very important for the health and function of the human body impacting muscle 
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strength, body posture, and coordination. The tone and contraction of the muscles rely heavily on 
their ability to respond to stimulation signals nerve cells relay from the brain [14].  
 
 
Figure 4. The regulation of muscle contraction via ion channels. [15] 
 
The sliding filament theory is the accepted explanation for how muscles contract to 
produce a force [15]. Each muscle is made up of small fibers called myofibrils. The myofibrils 
have actin and myosin which slide in and out of each other, generating a contraction. There are 
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four major steps in the process. The first step is muscle activation where the motor nerve sends 
an impulse that arrives at the neuromuscular junction. The sarcoplasmic reticulum is stimulated 
and releases calcium into the muscle cell. Next, the calcium binds with troponin which binds the 
actin and myosin together. ATP energy is used to bind and contract the actin and myosin 
together. After, actin and myosin remain strongly bonded because ATP is synthesized again. The 
final step is relaxation. During this step stimulation to the nerves is stopped and calcium is 
pumped back into the sarcoplasmic reticulum. This breaks the bond between the actin and 
myosin. Once the actin and myosin are separated, the muscle can relax. Additionally, relaxation 
also occurs when there is no more ATP [15].   
 
 
Figure 5. The regulation of muscle contraction via ion channels. [16] 
 
There are three main “rules” for there to be a muscle contraction. The first is that there 
must be a neural stimulus. The second, there must be calcium inside the muscle cells. Finally, 
ATP must be available for the bonding of actin and myosin to occur. There are four main ways 
to stop a contraction. The first is fatigue of the energy system. This occurs when there is no more 
ATP left so the cells stop contracting. Next, the nervous system is unable to produce enough 
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impulses to release the calcium into the muscle cells. Voluntary nervous system control can send 
signals to stop the release of calcium ions, stopping the contractions. Finally, a sensory neuron 
will tell the brain that the muscle is being injured while lifting something heavy, and stop the 
contraction.  
If the process described above is interrupted at any stage from the reception of the nerve 
signal and the action of the filament proteins then the muscle itself will lose the normal capacity 
it has for contraction and tone [16]. As an extreme the muscle could be limp and weak as a result 
or the muscle can be involuntarily active and not able to relax. Both of these extremes or any 
variation in between would definitely affect the physical capabilities of an individual who 
requires constant and consistent muscle stimulation and strength.  
2.3 Tissue Regeneration 
Tissue regeneration is the regrowth of new tissue to a damaged or injured site. In the case 
of severe damage, there is typically volumetric muscle loss. In the case of severe injuries the 
tissue will scar over, the tissue will lose physiological function. This section outlines the 
regeneration process and its impact in tissue engineering.  
2.3.1 Function & Purpose 
Injuries to the skeletal muscle system are common. The ability of the muscle to repair 
itself after damage is largely dependent upon the type and severity of the injury. If an injury 
diminishes the muscle by more than 20%, the muscle will form scar tissue and the natural repair 
process will not occur [17]. If the damage is not as severe, the muscle will undergo the 
regeneration process. The repair process can be divided into three main phases [17]:  
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1. The first phase is the destruction and inflammatory phase. During this phase 
myofibers experience rupture and necrosis and experience a cellular inflammatory 
response.  
2. The second phase is focused on the phagocytosis of the necrotic muscle fibers. 
This phase includes the generation of muscle fibers and formation of scar tissue.  
3. The third phase is the remodeling phase. The muscle fibers reorganize and restore 
function to the muscle.  
Repair to a muscle with volumetric loss occurs differently. Figure 6, below, demonstrates 
the repair process. Step A in the figure below shows the myofibers being degraded by the 
invading inflammatory cells. This removes cellular debris and attracts satellite cells. Step B 
shows the satellite cells differentiating into myoblasts. Next, step C, is where fibroblasts deposit 
scar tissue to the impacted area.  New muscle tissue is formed in step D by forming myotubes 
that fuse with existing myofibers. This process is known as myogenesis. In injuries with large 
volumetric loss, scar tissue begins forming faster than the myogenesis process, seen in step E. 
The scar tissue prevents the myofibers from closing the wound. This results in the lack of 
neuromuscular junctions in the damaged tissue of step F.    
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Figure 6. Repair following volumetric muscle loss. [17]  
2.3.2 Regeneration in Tissue Engineering  
Tissue engineering aims to create a model that accurately mimics native tissue. In-vivo, 
tissue engineering aims to replace loss or damaged tissue by sending out progenitor cells or 
scaffolds to regenerate the tissue [18]. The aim of regeneration in tissue engineering is to replace 
loss or damaged tissue. Tissue engineering implements biomaterials that mimic the extracellular 
matrix in order to promote the growth, differentiation, and alignment of cells [19]. Regeneration 
of tissue via engineering can repair tissue that would otherwise lose function. Implantation of 
engineered skeletal muscle tissue has been shown to accelerate functional recovery [19].  
2.4 In-vitro Engineered Muscle Tissue 
Developing an in-vitro engineered skeletal muscle model poses a challenge due to the 
complex nature of native tissue. Recreating similar maturation and alignment of cells found in-
vivo is difficult. Currently, there is no technology that creates an engineered muscle tissue that 
mimics the packed, uniformly aligned, and differentiated myofibers that make up native tissue 
[20]. However, there are techniques that can aid in the maturation process. Electrical and 
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mechanical stimulation have been shown to increase the biomimetic properties. The following 
section outlines current tissue engineering approaches in the industry.  
2.4.1 Tissue Engineering Approaches  
There are multiple techniques for tissue repair and regeneration of skeletal muscle tissue. 
One strategy is to use biomaterials to rebuild tissue [21]. New materials such as 
tetrafluoroethylene and silicone are used to provide structure to the muscle, but lack the 
functional component that is found in native tissue. A better understanding of the extracellular 
matrix and the role it plays in the body, provides new biomaterials that have been designed to 
better mimic in vivo tissue. There are three main types of biomaterials that are used in tissue 
engineering [21]. The first is naturally derived materials such as collagen and alginate. Next is 
acellular tissue matrices like bladder submucosa. Lastly, is synthetic polymers such as PGA, 
PLA, and PLGA. The first two classes, naturally derived materials and acellular tissue matrices, 
have been shown to display regeneration in muscle tissue. Synthetic polymers are able to be 
produced on a large scale and have controllable properties like strength and degradation rate. In 
all three classes, the biomaterials aim to replicate the mechanical and biological function of 
native tissue. The aim is to have the cells adhere and grow around and on the biomaterial in order 
to form new tissue. Muscle cells are anchorage dependent, meaning they will die if they do not 
have a substrate to attach to. In this strategy, it is important for the biomaterial to be compatible 
with the body. An incompatible material will cause an inflammatory response and be rejected.  
In addition to biomaterials, another tissue engineering approach is the implementation of 
scaffolds. The scaffolds are used to mimic the structure of in-vivo conditions, including the 
extracellular matrix to allow for cells to adhere, differentiate and mature in the same manner 
found in-vivo [22]. Two techniques are typically used: top-down and bottom-up approaches. In 
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the top-down approach, the scaffold the cells are cultured on is designed to mimic the structure, 
composition, and mechanical properties of the tissue [22]. In the bottom-up approach, the aim is 
to create a scaffold that is more biomimetic by replicating the functional unit of the tissue [22]. 
The scaffolds should be designed to be porous. The pores allow the cells to migrate throughout 
the scaffold and allows nutrients and oxygen to diffuse. Cells showed better maturation and 
differentiation on a 3D scaffold when compared to cells cultured on a 2D surface [22]. Scaffolds 
function as a microstructure for the development of engineered tissue.  
The cell selection process is an important factor in tissue engineering. Growth of in-vitro 
tissue largely depends on the accessibility of tissue-specific cellular phenotypes [22]. The cells 
must be able to recapitulate the characteristics of native tissue. Additionally, the number of cells 
being cultured should represent the physiologically demand. When testing drugs in pre-clinical 
and clinical trials, it is important to use human cells, as other types may not illicit the same drug 
response. Cells that are cultured from humans are adult primary cells, but are hard to isolate and 
remove. Adult primary cells have a short life same and slow proliferation rate [22]. Stem cells 
have been used as an alternative. Stem cells are undifferentiated and are able to differentiate into 
multiple different specialized cells. The main concern when using stem cells is controlling the 
desired lineage and the immature phenotype with a similar expression profile to fetal cells [22].  
2.4.3 Limitations of Current Techniques 
Currently on the market there is no set standard for how to properly engineer muscle 
tissue. There is no accurate in-vitro model that has been developed, therefore there is limitations 
to every technique. In native tissue, cells are able to differentiate and expand as long as they have 
an anchor point. In-vitro cells are limited to the anchorage site and are not able to proliferate as 
freely [23]. In-vitro, the tissue often lacks the same density and alignment as native tissue. The 
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extracellular matrix found in-vivo is difficult to replicate, usually utilizing proteins that have 
been left over from the hydrogel assembly. In some cases, the use of a 2-dimensional surface has 
been utilized. The 2D surface is non-ideal as it resulted in the cells lifting from the surface and 
consequently dying. Additionally, native tissue experiences regular exercise and stimulation in 
order to increase alignment and strength. It is difficult to exercise the muscle in the same manner 
ex-vivo. Matching the oxygen and nutrient supply of native tissue is another obstacle [24]. There 
is a limited amount of nutrient and oxygen that can be supplied to in-vitro muscle tissue. 
Matching the mechanics of the vascular system in native tissue is difficult, as there is no 
predetermined amount.  
2.5 Strategies for Advancement:  
In an ex-vivo or in-vitro muscular environment there are many crucial characteristics 
from native tissue which must be mimicked.  In order for a good predictive disease model the 
cells and tissue must mature and function properly. That way, they possess the same traits as 
native tissue and can be used to accurately learn about the potential treatments and cures for 
diseases related to skeletal muscle function. Some vital characteristics for the tissue to obtain 
include; fiber alignment, fiber strength, cell density, and vascularization.  
2.5.1 Electrical Stimulation  
Electrical pulse stimulation is necessary for the development of skeletal muscle. In the 
body, the central nervous system sends electrical impulses from the motor neurons. This is an 
important step in muscle development and maturation [25]. Mimicking of these crucial impulses 
is a core requirement for in vitro engineered skeletal muscle tissues. The main struggles of 
simulating electrical impulses ex vivo is however is controlling/perfecting the various 
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parameters; voltage, amplitude, pulse width, and pulse frequency so that the regimen properly 
induces maturation and functionality while avoiding electrochemical damage to the tissue [25]. 
2.5.2 Existing Methods for Electrical Stimulation of Engineered Muscle 
 Due to the importance of electrical stimulation to biomimetic tissue constructs in vitro, 
researchers have attempted to perfect a regimen. Considering the difficulty of perfecting all the 
parameters of electrical stimulation, there is no set standard in the industry.  
 A few methods which exist include the Myoforce Analysis Device (MAD) created and 
tested by Herman Vandenburgh, electrical pulse stimulation (EPS) outlined by Akira Ito et. al 
[25][26]. The MAD is an automated system that inserts electrodes into each well of a 96-well 
plate, implements a set stimulation regimen, and captures images of the contracting cells. This 
electrical stimulation device is encased and insulated for incubation of cell cultures. The 
specifications include a heated stage to keep the cells warm and lifts the plate up to electrodes 
which applied a 13V voltage, 40Hz frequency, over the course of 2 seconds with pulse widths of 
4ms[26]. In addition to the stimulation 40-60 images were captured of contractions and 
automatically processed by a MatLab software algorithm to measure force [26]. In the Akira Ito 
model, the electrical pulse stimulation was applied to mouse myoblasts cultured and 
differentiated for four days. The cells were housed in 4 and 6 well plates in a chamber, and 
stimulated by two carbon electrodes at voltage rates of 0.1,0.3, and 0.5V/mm and pulse widths of 
2,4, and 10 ms [25]. The analysis of twitch peak forces allowed for the researchers to conclude 
that EPS aided in proper functional development of engineered in vitro skeletal muscle. A 
continuous electrical regimen of 0.3V/mm amplitude, 4ms pulse width, and 1Hz frequency 
showed the most promising results of a 4.5 fold increase in muscle force after 14 days [25]. 
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2.5.3 Mechanical Stimulation 
 Cells, such as muscular cells, are aware and sensitive to the changes which occur in their 
environment, including certain physical and mechanical stimuli. A specific cellular response 
occurs as a result of these stimuli, which has been modeled and analyzed in in vitro studies for 
better knowledge on how muscles grow and function outside of the body [27]. There is an 
inherent and vital relationship between the cytoskeletal architecture of skeletal muscle and their 
proper maturation and functionality [27].   
 Specific physical training such as endurance and resistance directly impacts crucial 
characteristics of muscle fiber development and function [28]. Endurance training reduces the 
susceptibility of muscle fibers to fatigue by increasing aerobic capacity, while resistance training 
correlates to an increase in the number and size of myofibrils called hypertrophy [28]. These 
mechanisms are important to both native and engineered muscle tissues. In the case of 
engineered muscle, recreating these mechanisms are crucial to biomimetic tissues ex vivo.  
2.5.4 Existing Methods for Mechanical Stimulation of Engineered Muscle 
Model systems utilize tensile forces for mechanical stimulation in vitro to simulate in 
vivo conditions. External mechanical forces applied to muscle tissues correlate to growth rates 
and metabolic adaptations [29]. Models created and tested with muscle tissues represent key 
research and findings about the relationship between mechanical transduction processes and cell 
and molecular interactions [29]. 
 Over the years there have been many devices and studies performed to physically 
stimulate muscle cells in vitro and analyze the effects. One of the first researchers to make 
headway was Vandenberg et al, who experimented with bioreactors with mechanical stimulation. 
The first two which were developed by Vandenberg researchers include a Mechanical Cell 
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Stimulator Model I and Model II [29]. The first model is pictured below and the basic concept is 
sandwiching of circular tissue constructs with Teflon, and collagen coated Silastic membranes; 
while a motor pushes up a stainless steel membrane with prongs to push up on the constructs 
[29]. Mechanical stimulation was applied over the course of days to help the tissues develop 
structural strength without rupturing.  
 
 
 
 
Figure 7. Schematic of Mechanical Cell Stimulator Model I [29] 
 
 The second model is pictured below and utilized a similar culturing methods however the 
elastic wells were rectangular and mechanical stimuli were applied in one dimension horizontally 
[25]. This regimen allowed for myoblast orientation, proliferation, fusion, and growth rates [25].  
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Figure 8. Schematic of Mechanical Cell Stimulator Model II [29] 
 
 Other notable studies continued to adapt elements of the design and process including 
construct size and shape, stimulus regimen, and means of achieving mechanical conditioning. In 
a study conducted by Candiani et al, a biomimetic stretch regimen over 10 days of 3.3% steady 
ramp stretch every 2 days with a 0.5Hz cyclic 5-pulse which increased protein expression of 
mouse myoblasts [25]. Another study conducted by Machingal et al conditioned muscle 
progenitor cells over a week with a 10% stretch 3 times per minute for 5 minutes every hour 
[25]. These constructs showed promising functional recovery and biomechanical properties [25]. 
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Researchers with Ito et al developed a magnetic force-based tissue engineering technique that 
utilized nanoparticles for magnetic labeling of mouse myoblasts which were seeded as a ring and 
stimulated using a round magnet [25]. While some or many of these current methods show 
promise at creating biomimetic muscle tissue constructs for knowledge on myoblast 
differentiation and function, and for use in predictive disease modeling, new methods are 
continually being explored. 
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Chapter 3: Project Strategy 
3.1 Initial Client Statement 
The initial client statement is to design a system to create skeletal muscle in vitro using 
cultured myoblasts that is capable of facilitating both fiber alignment and mechanical or 
electrical conditioning. Additionally, the appropriate overall tissue dimensions must be 
determined as well as the optimal stage of myoblast differentiation with which to seed the system 
and the time required to achieve contractile function. The material selection issues with respect 
to provisional extracellular matrix, natural polymers such as fibrin/collagen, or artificials must be 
addressed and selected. Methods to measure contraction due to electrical stimulation and fiber 
strength must be designed and implemented. A requirement for supporting cells such as 
fibroblasts must be addressed. Finally, we must develop a process engineering strategy to include 
kinetics of muscle cell differentiation and maturation. 
3.2 Revised Client Statement 
Upon further discussion and review, the client statement was narrowed down and the 
goals were further specified. The revised client statement became: 
“Design an in-vitro system to mechanically stimulate engineered muscle in order enhance 
maturation. The system should be conducive to producing biomimetic tissue to be used with 
drug-screening technology.” 
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3.3 Design Requirements 
This section outlines the objectives and requirements of our project and device.  
3.3.1 Design Objectives 
The overall design objective is to enhance the maturation of in-vitro, engineered skeletal 
muscle tissue via mechanical stimulation.  
After reviewing the revised client statement, the main design objectives were listed in 
Table # 1, below. 
Table 1: List of Requirements 
Design Requirements 
Tissue anchorage 
Interface with high throughput format  
Method of measuring strain 
Non-cytotoxic 
Sterilizable 
Repeatable, reproducible 
Ability for 96-well culture plate removal 
 
The first requirement is to have an anchorage system for the tissue to adhere to. Tissue 
requires an anchoring system in order to grow and will die without a system. PDMS posts are 
typically used as an anchoring system. The device will have to be compatible with a high 
throughput format. This means that the system should be able to be used with drug screening 
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technology. A 96-well plate can be used in order to achieve high throughput. In order to ensure 
that the tissue is being exercised, the design must include a method of measuring strain. 
Typically, imaging can be used to measure the strain.  
The first objective speaks to the ability of our device in regard to its biomimicry. This 
means that the device should have good tissue maturity and density. In the examination of the 
Myomic drug screening platform the group discovered that this was one of the major limiting 
characteristics.  
In order for the in-vitro system to properly mimic native tissue, it must form densely 
packed, uniformly aligned, and differentiated myofibers [13]. Thus, it is crucial that this model 
address the past issues with dense, mature tissue formation. The in-vitro skeletal muscle tissue 
developed needs to mimic native tissue formation.  
The final model must be reproducible. This means that the contractile function, fiber 
length, diameter, and density must be able to be produced repeatedly. A standard must designed 
to achieve repeatable results.  
The third design objective aims to build off the positive, functioning aspects of the 
Myomics drug-screening platform. This means factoring in the well-plate for growing the tissues 
as well as posts which can anchor the cells. The device should also incorporate the assessment 
mechanism of contractile function utilized in the Myomics platform. Building off the aspects of 
this platform which work well as a skeletal muscle model will allow the group to focus on other 
aspects which can be improved for the new model. A removable 96-well plate can be used for 
culturing in an incubator.  
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3.3.2 Design Specifications and Constraints 
The design constraints we have developed from the aforementioned design requirements 
are as follows: 
Table 2: Design Specifications 
Design Specification Technical Specification  
Mechanical stimulation 0-23% strain of original tissue length 
Operative under physiological conditions 
(incubator environment) 
37 °C 
5-7% CO2 
95% humidity  
Anchorage system PDMS posts 
Frequency of strain application 0.5-1.5Hz 
 
● Culture and maintain in physiological conditions (incubator environment): 
○ 37 °C 
○ 5—7% CO2 
○ 95% humidity 
Because we are attempting to produce the most accurate human model of skeletal muscle 
tissue to-date, we must ensure that our system operates well in typical human physiological 
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conditions, or in an incubator environment. This environment is comprised of the above 
attributes. 
Specific to engineering tissues for use as in-vitro models, we will be utilizing a 3D tissue 
engineering technique. The determination of which method creates the most accurate 
environment biomimetic to the extracellular matrix in which native muscle tissue exists is 
crucial. 
In order to create an accurate model, we must develop a standard for skeletal tissue 
engineering that is reproducible, meaning, with our methods and procedure, the ability to 
engineer skeletal muscle tissue with consistency in the above technical areas. This is a crucial 
step if we are to improve on current research methods of in-vitro skeletal muscle. Further 
constraints of this project include the size.  
The anchorage system are necessary for the viability of the cells. PDMS posts are used in 
the WPI labs and create an environment for the cells to be seeded to. Additionally, the frequency 
of the applied strain should be between 0.5-1.5 Hz. This mimics what is found in-vivo.  
Table 3 lists the design constraints. 
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Table 3: Design Constraints 
Constraint Specification of Constraint  
Compatible with a standard culture plate 128x85x14mm 
Materials must be appropriate for use with 
live tissue constructs in the future  
Biocompatible with cells  
Budget $750 
Timeline  < 9 months timeline 
 
3.3.3 Design Functions 
Given the stipulated design constraints above, we are able to create a more 
comprehensive list of necessary design functions. These are as follows: 
● Nutrient perfusion 
● Fiber anchorage 
● Mechanical stimulation 
○ Application of strain (anchorage prevents collapse) 
○ Stimulation 
● Measurement of force (to ensure accurate biomimicry) 
○ Imaging 
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Below is the function-means table for aforementioned design functions. 
Table 4: Function-Means Chart 
Function Means Means Means 
Culture Environment 96-well plate Commercial “enhanced” 
culture flasks 
Petri dish 
Nutrient Perfusion    
Fiber Anchorage PDMS posts Metallic alloy posts Hydrogel posts 
Mechanical Stimulation Magnets Sub-matricial air-pocket  Hydraulic piston 
Measurement of Stress Force transducer 
(utilize LabView) 
  
Measurement of Strain ImageJ Calipers   
 
Part 3.3 Design Standards 
The design of a human skeletal muscle tissue model requires attention to be paid in 
regard to industry and ethical standards. The adherence to such standards will ensure the safety, 
effectiveness, and legality of the system. Below is a table of the relevant industry standards to the 
design and testing of a human skeletal muscle tissue model: 
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Table 5: Industry Standards 
ISO 22442-2:2007 Sourcing, collection, handling of 
animals and tissues 
ISO 13022:2012 Management of viable human cells 
ISO 10993-1:2009 Biological evaluation of 
biocompatibility of medical devices 
ISO 17422:2002 Plastic environment impact 
ISO 7712:1985 Use of disposable micropipettes 
ISO 7550:1985 Use of disposable serological pipettes 
 
These various standards apply to the tissue and cell cultures which will be central to the 
design of the skeletal muscle tissue system. There are many standards associated with the use of 
tissue cultures. Adhering to such standards will overall ensure that improper or poor handling of 
living tissues will not impact the accuracy of the results acquired. The standards which directly 
relate to biocompatibility are also essential to the operation of this project. These standards will 
ensure a good relationship between the living cells and the device materials, meaning that the 
materials used in the design will not harm the muscle cells or affect their growth and maturation. 
As a result of the materials negatively impacting the cells, the results of the project would be 
deemed inaccurate. As a result of the adherence to these standards, all materials considered and 
used in the design process and final design will be biocompatible. Another important aspect is 
the prevention of contamination or toxification of the muscle cells. The industry standards for 
sterility will play a major role in protecting the viability of the cells. The environmental 
standards also play a role in this project as they will serve to protect the environment from 
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potential threats or damage. These standards give a way for the potential impact on the 
environment of the device. The avoidance of accumulating material waste and the safe use of 
hazardous materials are also ensured by following these industry standards. Lastly the standards 
which apply to the laboratory equipment will be important in assessing the efficacy of the device 
created as well as ensuring the device utilizes common laboratory equipment and standards.  
Financial Statement 
The financial considerations for the group involve the total budget of $750. In regards to 
design materials, such as well plates and supplies, the team must remain within this budget 
throughout the course of the project.  
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Chapter 4: Design Process 
4.1 Need Analysis  
In order to create a skeletal muscle tissue model there are a series of criteria which need 
to be considered and included in the design. When considering parameters which may not fall on 
the technical side there are a series of desires which arise in the design and creation of such a 
device. Outlining the needs and wants of this design project will highlight what will be 
accomplished. Below is a table of design requirements. 
One of the primary goals is the growth of viable skeletal muscle tissue. Characteristics 
that will contribute to viable tissue include muscle fibers which can metabolize, proliferate, and 
contract. The application of stimuli both of mechanical and electrical origin will contribute to the 
ability of the skeletal muscle cells to differentiate, grow, proliferate, and exercise. In the human 
body, both electrical and mechanical impulses force muscle cells to grow and strengthen. Thus in 
an in-vitro model, the cells must be subject to the same impulses in order for them to mimic the 
in-vivo cells. Muscles subject to shear stress and cyclic strain are as a result much denser and 
thicker. The recommended mechanical stimulation falls between 10 and 15 percent stress and 
relaxation from the initial tissue length. Anchorage and materials such as scaffolds are crucial 
when working with muscle cells due to the need for muscle cells to grow on biocompatible, 
dimensionally appropriate scaffolds that also provide a mechanism of stabilization. Myofibers 
tend to have a diameter of 10-100μm, and thus this must be addressed by the design size. This 
project works with living sensitive cells, meaning that contamination and toxicity must be 
avoided in order to prevent slow growth, adverse effects, or cell death. 
The project wants encompass additional desires in order to elevate the overall design. 
One of the desires is to achieve biomimicry. While this achievement would produce an accurate 
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and comprehensive model for study, it is known that in-vitro muscle cell biomimicry is 
extremely difficult. Currently there is a lack in high-throughput technology as well as a true and 
accurate skeletal muscle tissue model. For these reasons it seems that great usability and 
reproducibility could be sacrificed in order to focus on other vital characteristics.  
4.2 Concept Map, Design, Prototyping, Modeling, & Feasibility Studies 
The design functions mapped out in chapter three are comprehensive concepts, each with 
sets of sub-functions. Each function will be mapped out and analyzed as a functional block. The 
design process will be applied to each functional block starting with supporting and growing the 
cells, mechanically stimulating the cells, and measuring the displacement of the posts when 
mechanically stimulated. 
After brainstorming various design concepts, we are considering the design of two 
possible systems in which to stimulate, strengthen and maintain our cells. The chart below maps 
out various design requirements that must be incorporated into the system we are developing, as 
well as various means of accomplishing or meeting those requirements. The design components 
circled in red are those which pertain to our two preliminary concepts and are explained below 
the diagram. 
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Figure 9. Design attributes are illustrated and prioritized. 
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Table 6: Functional Blocks of Conceptual Designs  
96-well Plate Compatible with lab equipment and living 
cells, will provide housing/culturing 
environment for muscle cells 
 
PDMS Posts Anchorage mechanism, biocompatibility, 
allow for physical manipulation and cellular 
exercise 
 
Metallic Alloy Posts  Anchorage mechanism, physical magnetic 
manipulation and cellular exercise 
 
Submatricial Air-pocket Manipulation of PDMS posts for mechanical 
stimulation- allows for indirect manipulation 
(i.e. use of air to change volume of pocket, 
which will in turn cause movement of PDMS 
posts) 
 
Magnets Manipulation of metallic alloy posts for 
mechanical stimulation- allows for indirect 
manipulation (i.e. use of magnetic field to 
influence movement of metal posts) 
 
 
Figure 10. Preliminary illustration of Design Concept 1.     Figure 11. Preliminary illustration of Design Concept 2. 
1. Use of PDMS Posts and Manipulation by Submatricial Air-Pocket 
The design of a system that utilizes flexible PDMS posts in conjunction with Myomics 
drug-screening platform was used by the 2016 WPI design team. With the development of their 
Sliding Comb Rack, the team was able to develop a system which applies a stress and 
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electrically stimulates muscle cells. This design, however, only manipulated the PDMS posts in 
one direction. In a new approach, we will attempt to modify and improve upon this past design. 
Consistent with our needs, the implementation of a submatricial air pocket (see diagram below) 
would allow us to manipulate the posts in an orientation which stretches the muscle cell. This is 
crucial for the development of fibers which resemble those of native muscle tissue. In addition to 
this, withdrawal of air from the submatricial air-pocket would shorten the muscle cells and 
simulate atrophy, or the degeneration of the cells.  
2. Use of Metallic-Alloy Posts and Manipulation by Magnet 
In an alternative approach to apply a mechanical stimulus to the cells, we are considering 
the use of metallic posts within our culture system. This development entertains the same logic 
as the aforementioned design concept; designing a system in which we can both apply and 
relieve stress from the muscle fibers. With careful determination of magnetic poles and fields 
within the system, there is potential for the application of a magnetic field to cause movement of 
the metallic posts, either toward each other, to relieve stress, or away from each other, to apply a 
stress. Factors to consider moving forward with this design include the biocompatibility of the 
alloy used, direction of magnetic fields, potential interference of opposing magnetic fields, 
potential adverse effects of a relatively strong magnetic field on the muscle fibers, the shielding 
of test environment from outside magnetic fields, among others. 
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After reviewing the preliminary designs, the team came up with 4 other alternative 
designs: 
 
 
Figure 12. Schematic of Alternative Design #1. 
 
 
 
Figure 13. Schematic of Alternative Design #2. 
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Figure 14. Schematic of Alternative Design #3. 
 
 
Figure 15. Schematic of Alternative Design #4. 
 
The first design would use mechanical actuators to move the PDMS posts and 
mechanically stimulate the tissue. The second alternative design would use a mechanical spinner 
placed inside the well. Cells would be seeded between the spinner and side of the well. The 
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spinning action would stretch and exercise the cells. Alternative design 3 would use a hydraulic 
pump and a flexible bottom on a well plate to deflect the PDMS posts. Alternative design 4 
would use a spring system inside a well plate to mechanically stretch and compress the tissue. 
The cells would be seeded in the grooves of the spring and attach to the top and bottom parts of 
the grooves.  
 After discussing each design with our client, design number 3 was further expanded. The 
same concept was used in the creation of the final design. A pegged plate placed on a jack was 
used in place of the hydraulic lift. The pegged plate would push up into the bottom of the 96-well 
plate with a flexible PDMS bottom. The jack would act as a lift system to push the pegged plate 
up into the well, causing the PDMS posts to deflect. Below is the schematic for the pegged plate 
fitting into the bottom of the 96-well plate: 
 
Figure 16. SolidWorks schematic of pegged plate/96-well plate assembly. 
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 The pegged plate is attached to a jack that elevates the pegs to apply an upward force on 
the bottom of the wells. The PDMS posts are placed inside the well and deflect as shown in 
Figure 17, below:   
Figure 17. Illustration of mechanical stimulation means. 
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Chapter 5: Design Verification 
This chapter outlines the facts considered and experiments conducted in order to confirm 
that the decided-upon design meets its stipulated design objectives, requirements and 
specifications. The actions taken during the design verification process ensure that the final 
design proposes an adequate seeding system, and means of maintaining sterility, and method of 
mechanical stimulation. 
5.1 Seeding System Verification 
The following section details and verifies how the chosen design offers a suitable seeding 
system for the intended use of the system. 
5.1.1 Adequacy of Seeding System 
As stated in the Background Research section, polydimethylsiloxane (PDMS), a silicon-
based organic polymer, has been incorporated into past and current research experiments for the 
mechanical stimulation of engineered muscle. For this project, the team effectively redesigned 
the standard 96-well plate, curing flexible PDMS post inserts into a PDMS layer with the 
dimensions of the bottom of a 96-well plate. In order to ensure that the fabricated PDMS layer 
would remain intact, and that the PDMS post inserts would remain sealed within the PDMS 
layer, the team produced three bottom layers with the post inserts. The same production protocol 
was used for each, and each of the three layers were subject to “destructive” testing; after 
subjecting the PDMS layers to multiaxial stretch with forces greater than that with which the 
PDMS posts would be flexed by the pegged plate, the team was able to verify that the PDMS-
bottom/PDMS-post assembly would stand as an effective choice of seeding system. 
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5.2 Mechanical Stimulation Verification 
The following section describes the ability of the system to achieve adequate flexion of 
the PDMS posts. 
5.2.1 Function of Pegged Plate 
In order to verify that the pegged plate and 96-well plate assembly was effectively flexing 
the PDMS bottom, the team first constructed a modified SolidWorks model of the original 
pegged plate, featuring more pointed pegs than the flat-topped pegs the concept originated with. 
The computer-aided design files were converted into the appropriate 3D-printing file format, and 
the plate was made with PLA plastic. Upon completion of printing, the team fixed the pegged 
plate to the table jack purchased for the design assembly. The 96-well plate assembly, with its 
flexible PDMS bottom and posts, was placed directly above the plate, and pressure was applied 
in the downward direction. The observance of posts flexion allowed the team to verify the 
pegged plate as an adequate means of mechanical stimulation. 
5.2.2 Function of Arduino Uno, NEMA Stepper Motor, Table Jack Assembly 
To verify the functional capability of the Arduino Uno to operate the NEMA Stepper 
Motor, and the capability of the motor to control the jack, simple tests were conducted. After 
assembling all three components, the Arduino Uno was connected to a continuous power source, 
such as a computer or 120V wall outlet. The team then continuously altered the Arduino code to 
produce varied responses from the motor, and observed whether the jack demonstrated the 
desired mechanical response. The assembly proved to function most efficiently when the motor 
steps taken remained below 200 steps; the motor exhibited inadequate strength when the motor 
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step input was too high. However, due to time constraints, the team was unable to modify both 
the motor and jack components of the final assembly. 
5.2.3 Function of 96-Well Plate Stand 
The provision of the 96-well plate stand allows for removal of the 96-well culture plate, 
and its rigid nature facilitates the acquisition of repeatable and reproducible strain regimens. 
5.3 Final Experiment 
The following section explains the final experiment that was carried out once the various 
capabilities of the design were verified. The experiment aimed to review the theoretical ability of 
the device to mechanically stimulate mature muscle tissue.  
5.3.1 Final Experiment 
Two crucial variables were defined before the final experiment was initiated. Percent 
strain was defined as the percent increase in distance between the two PDMS posts from the 
relaxed state to the flexed state. The z-displacement was defined as the upward vertical distance 
traveled by the pegged plate from a constant starting position, which was consistent for each 
trial. 
 A total of four experimental conditions were stipulated. For each separate condition, the 
Arduino Uno code was altered in order to program the NEMA Stepper Motor to perform various 
steps in the backward direction; the motor executed 300 steps, 100 steps, 50 steps, and 30 steps. 
The backward steps resulted in upward movement of the jack and thus, pegged plate. For three of 
these conditions, 100 steps, 50 steps, and 30 steps, the motor was programmed to perform an 
equal number of steps in the opposite direction so that constant z-displacement could be 
maintained for each respective test. Due to limitations posed by motor strength, the execution of 
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300 steps in the upward direction was belabored, and the team found that alternatively 
programming the motor to perform 150 steps for downward movement resulted in the 
maintenance of z-displacement throughout the trial. The the top surface of the jack was manually 
positioned 3.23mm below the PDMS bottom before the commencement of the trials. In order to 
maintain this starting distance for each trial, the NEMA Stepper Motor was always deactivated 
upon completion of downward movement, or upon its return to the initial starting position.  
 To begin each trial, the tops of all PDMS posts were marked in black, to provide fiducial 
points for data analysis. Then, the system was allowed to run for a prolonged period of time, 
estimated to be > 10 minutes for each trial. After doing so, confirming the proper operation of all 
components, visual data was logged with video capture. Videos were taken directly above the 
wells, so that, in their relaxed state, the PDMS posts appeared as singular points. A total of four 
videos were recorded above the 96-well plate. Figure 18 and 19 demonstrate the camera 
positioning above the device. 
 
 
Figure 18. Relaxed state of PDMS posts.  Figure 19. Flexed state of PDMS posts. 
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For the express purpose of providing a proof-of-concept, three wells containing the 
PDMS post inserts were tested at different locations on the plate, under the four aforementioned 
conditions. The team then uploaded the visual data files into a video editing software to capture 
freeze-frame images of the PDMS posts at relaxation and at flexion. These freeze-frames were 
captured for every relaxation-flexion interval for the extent of each video, and organized into 
condition-specific files. Thereafter, the team uploaded each image file to ImageJ, an image 
processing program, to measure distance between PDMS posts. In order to calibrate the software, 
a known distance was incorporated into the video frames during recording. This allowed for the 
establishment of a universal pixel/millimeter ratio, which could be used for better accuracy 
across all images. Figure 20 shows the ImageJ interface. 
 
Figure 20. Demonstration of measurement in ImageJ. 
 
Once measurements of relaxed and flexed states for each condition were documented in a 
spreadsheet, the team proceeded to calculate the percent strain using the following equation: 
. Because the team’s stipulated experimental 
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conditions were in terms of motor steps rather than z-displacement, an empirically derived 
proportion was used to calculate the z-displacement per motor step condition. The resulting z-
displacements found were as follows: 4158μm (300 steps); 1386μm (100 steps); 693μm (50 
steps); 415.8μm (30 steps). The average percent strain for each condition is plotted as a function 
of z-displacement in Figure 21.  
 
 
Figure 21. Percent strain plotted as a function of z-displacement. 
 
The frequency at which various strains were applied was also measured upon completion 
of the trials. The team again utilized video editing software, and was able to distinguish singular 
intervals of flexion. The duration of one interval per condition was documented in seconds. The 
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reciprocal of these times, , were taken to attain flexion 
frequency. The various stipulated, theoretical and empirical values are quantified in Table 7. 
 
Table 7: Empirical and Theoretical Results Relative to Design Condition 
Motor steps 
(upward 
direction) 
Motor steps 
(downward 
direction) 
Resulting z-
displacement 
of pegged 
plate (μm) 
Average strain 
of PDMS 
posts (%) 
Standard 
deviation 
 
Frequenc
y (Hz) 
Samples 
per trial 
30 30 415.8 5.59 0.710 0.6 10 
50 50 693 16.08 0.804 0.45 10 
100 100 1386 19.82 0.704 0.3 10 
300 150 4158 23.82 0.577 0.2 10 
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Chapter 6: Final Design and Validation 
This chapter outlines and demonstrates the incorporation of each design component 
within the follow design. The chapter also discusses the industry standards and potential social 
impact of the project.  
6.1 Device Overview 
 
 
Figure 22. An overview of design components. 
 
The system is powered using a NEMA stepper motor that is hooked up to an Arduino 
UNO R3. The Arduino UNO R3 can be programmed to change the number of rotations the 
stepper motor turns the jack. An increased number of steps will move the jack further up, 
increasing the deflection of the PDMS posts. The rubber motor-jack connector connects the 
motor to the jack and is designed to be lightweight so it does not interfere with the up and down 
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movement of the jack. The 96-well plate stand holds the bottomless 96-well plate above the jack. 
The seeding system consists of a flexible PDMS bottom (placed on the underside of the 96-well 
plate) with PDMS posts placed in the center of the well. On the top of the jack there is a pegged 
stimulation plate designed so each of the individual pegs can enter the center of each well. All 
components are placed in the stainless steel lab stand table jack with cutouts to accommodate 
each of the different components.  
6.2 Device Validation 
This section outlines the validity of the design in a social context.  
6.2.1 Industry Standards 
Industry standards are put in place in order to ensure safety of the user when designing 
and working with biological substances. These standards come from the International 
Organization of Standardization (ISO) and set national standards for industrial and commercial 
use. ISO 18458:2015 and ISO 18459:2015 are standards on how to produce the constructs when 
creating biomimetic tissue. The biocompatibility of a medical device with biologics is ISO 
10993-1. The in-vitro cytotoxicity of medical devices is standardized and sterilization protocol is 
in ISO 10993-5:2009 and ISP 11737-2:2009, respectively. ISO 17422:2002 ensures the device 
has no negative environmental impact.  
6.2.2 Economic Impact 
Currently, the device would have little impact on the overall economy. In the future, this 
could expedite the drug development process by creating a biomimetic tissue muscle. This would 
help those living with muscular disorder have a better quality of life. This would also decrease 
the cost for the development of treatments and therapies. Rapid testing of drugs could further 
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develop the economy, allowing for new products to be brought to the market more often. This 
could impact patients by lowering the costs of drugs do to the increase in competition. The 
market could be better balanced, with no single company holding stake over the entire drug and 
market.  
6.2.3 Environmental Impact 
The device itself would have little to no environmental impact. Should the scope of 
environmental impact be broadened, it’s conceivable that each of the design components and the 
materials used to produce them could have an environmental impact. 
6.2.4 Societal Impact 
Engineered skeletal muscle tissue can be used to develop treatments and cures for 
musculoskeletal disorders. A device that can properly maturate in-vitro skeletal muscle tissue 
can be used in pharmaceuticals. With further development, the device could possibly maturate 
tissue to mimic native tissue. If this occurs, society would see an improvement in the speed and 
distribution of curative medicine for disorders such as DMD and atrophy. The device could also 
be used to culture different types of cells, resulting in cures for other tissue or physiological 
issues. Additionally, an accurate in-vitro model could eliminate the need for animal testing 
during the drug testing process. Although, testing on animals does not always provide an 
accurate response in the human body. An accurate model will be able to better predict than 
methods that are currently being used. This will speed up the process, allowing for more time 
and money to be put into the development of other drugs for different ailments. Society would be 
positively impacted.  
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6.2.5 Political Impact 
Many political parties and politicians are funded by major pharmaceutical companies. 
Therefore, there are politicians that benefit from the way pharmaceutical companies are being 
ran now. If the device is able to further develop the drug creation process, this could change the 
way the industry is set up. Therefore, the unpredictable nature of politics could be impacted. 
Although not a direct correlation, the financial impact a device like this could bring to the 
pharmaceutical industry could impact the political climate.  
6.2.6 Ethical Concerns 
Currently, there are ethical concerns surrounding the drug creation process and testing 
protocols. Drugs have to go through extensive testing before being put on the market. This 
includes animal testing and human trials. Animal testing is used to see an in-vivo response of the 
drug. There is controversy about the ethical treatment of the animals. There are many 
organizations and groups who protest animal testing and try to stop the process. An accurate in-
vitro tissue model could eliminate the need for animal testing. Additionally, human trials are a 
part of the drug development model. Patients are able to sign up for trials, but the side effects of 
the drug are often not known. Also during human trials there is a control group that receives a 
placebo drug. Ethically, it is difficult because there is no way of choosing who receives the drug 
verse who receives the placebo. There is also no way of knowing the body’s reaction to a foreign 
compound prior to testing. An in-vitro skeletal muscle model could eliminate the need for animal 
and human testing. This would improve the ethical implications of the present drug testing 
methods.  
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6.2.7 Health and Safety Issues 
The current model of the device does not present any health and safety issues. Upon 
further development, the device would have to be compatible with an incubator in order to 
properly culture cells. There is no foreseeable safety or health issue to the user of the system. 
Since there is an electrical component, the device should not come in contact with water.  
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Chapter 7: Discussion 
This chapter will discuss the results from experiments outlined in Chapter 5, and the 
ways in which the findings support the team’s proof-on-concept. It will also be discussed 
whether the final design was able to meet or fell short of the various design objectives, 
requirements and specifications. 
7.1 General Discussion 
This section elaborates on the results of verification experiments outlined in Chapter 5.  
7.1.1 Seeding System Verification 
As outlined in Section 5.1, various tests were conducted to verify the seeding system 
decided upon for the final design. The first component selected by the team was the PDMS-
posts. Having been proven as an effective anchorage mechanism for engineered muscle tissue, 
the team decided to use this pre-existing component. While the posts are typically used within 
standard 96-well plates, the team decided to modify the standard plate so that it would be 
compatible with a means of mechanical stimulation which resides outside of the culture system. 
The multiaxial stretch testing of the PDMS layer/PDMS post assembly proved that it could 
withstand substantial forces due to stretch, and therefore was a viable design component for the 
final design system.  
7.1.2 Mechanical Stimulation Verification 
As outlined in Section 5.2, further tests were conducted to verify the means of 
mechanical stimulation decided upon for the final design. As previously described, the pegged 
plate was 3D-printed with PLA plastic. Tests to verify the ability of the pegged plate to flex the 
PDMS bottom layer, and thus flexion of the PDMS posts, proved successful. 
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The second test, as described in Section 5.2, was conducted to verify the functional 
capability of the Arduino/NEMA Stepper Motor/table jack assembly to achieve repeatable and 
reproducible agency. It was stated that the assembly proved to function most efficiently when the 
motor steps taken remained below 200 steps, because the motor exhibited inadequate strength 
when the motor step input was too high. This complication was both due to the nature of the jack 
as well as the physical capabilities of the NEMA Stepper Motor. When the jack operated at too 
low a depth, the amount of torque it required for elevation increased. The amount of torque 
necessary for all ranges of elevation for the jack was not achievable by the NEMA Stepper 
Motor; the assembly operated most efficiently when movement of the jack was initiated at higher 
elevations. To address this, the team made a point to operate the jack and conduct experiments at 
its maximum allowable height. This allowed for the experiments conducted at 100 steps, 50 steps 
and 30 steps to proceed unhindered, and the steps taken by the motor in the upward and 
downward directions were equal and opposite. The experiment conducted at 300 motor steps in 
elevation was modified so that the motor would take 150 steps in depression; it was found that 
these motor steps allowed for an equal and opposite elevation and depression interval for the 
jack, and data was collected as normal. 
7.2 Reviewing Design Requirements 
This section will detail where the final design met or fell short of the original design 
objectives, requirements and specifications. 
 
 
 69 
7.2.1 Fulfillment of Design Objectives 
The design objective stated at the outset of the project is as follows: 
To enhance the maturation and function of in-vitro, engineered skeletal muscle tissue via 
mechanical stimulation.  
While the final design verification did not include cell culturing, this is attributed solely 
to time constraints faced by the group. The design shows significant focus on mechanical 
stimulation, with the sole intention of repeatedly conditioning muscle tissues in vitro for 
biomimetic enhancements. Initial verifications of the mechanical stimulation mechanism 
provided a proof of the concept. As is, the device shows potential for adjustable stimulation 
regimens to enhance the maturation of in vitro-engineered muscle tissues.  
7.2.2 Fulfillment of Design Requirements 
The design requirements stated at the outset of the project are as follows: 
1. Tissue anchorage 
2. Interface with high-throughput format  
3. Method of measuring strain 
4. Non-cytotoxic 
5. Sterilizable 
6. Repeatable and reproducible 
 The several design requirements reiterated above were addressed in the completion of 
this design project. Tissue anchorage was an important requirement for the survival of the 
muscle cells ex vivo. This was addressed in the device design by the use of PDMS posts which 
are flexible and biocompatible. The posts have been used in past and present models, and work 
well with cell adhesion of the myoblasts as well as with the various electrical and mechanical 
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stimuli.  
The second requirement was the compatibility with high-throughput format due to the 
intended clinical use of the device in predictive disease modeling. The way in which the team 
addressed this requirement was the use of a 96-well plate due to its compatibility with current 
drug screening protocols. This ensures that when the time comes, this device will have the ability 
to be used in conjunction with high-throughput technologies.  
A method of measuring strain was a crucial requirement to quantify the mechanical 
stimulation capabilities of the device. The strain capabilities of the device needed to be 
monitored, especially for the purpose of creating similar regimens as in vivo. The team addressed 
this requirement by utilizing an interface with image capture and processing software. The 
requirements for non-cytotoxicity and sterility were crucial to protecting the viability of the cells 
in culture. The team addressed these concerns by selecting materials such as the standard 96-well 
plate and PDMS material, which are known to be sterile/sterilizable and also pose no threat to 
cell viability. In addition, the design allows for removal of the well plates for use in culture and 
incubation, and for the ability of well plates to be interchanged. The last requirements included 
repeatability and reproducibility. Both of these aspects are crucial for the verification and 
validation of any device. These requirements were addressed by the programmable motor 
through Arduino coding which allows for trials to run automatically over any amount of time.  
7.2.3 Fulfillment of Design Specifications 
The design specifications stated at the outset of the project are as follows: 
1. Mechanical stimulation 
a. 0-23% strain of original tissue length 
2. Operative under physiological conditions (incubator environment) 
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a. 37°C 
b. 5-7% CO2 
c. 95% humidity 
3. Anchorage system 
4. Frequency of strain application 
a. 0.5-1.5Hz 
The design specifications outlined above were all considered during the project design 
process. Final experimentation validated the capability of the system to achieve strains between 0 
and 23% of original tissue length. For the purpose of this project, muscle tissue was not seeded 
into the system, and therefore the percent strains are purely theoretical. Because results of the 
cyclic straining regimens demonstrated a proportionality between displacement of the pegged 
plate and percent strain between posts, it can be concluded that in order to achieve a desired 
strain, reference can be made to the results of the final experiment to identify an appropriate z-
displacement value.  Following suit, in future experiments, the percent strain achieved by the 
system can be tuned by alteration and updating of the Arduino programming.  
The final design is not capable of operating under physiological conditions. The team 
addresses this design specification in the Recommendations section. As previously described, the 
team decided to use PDMS post inserts as the fiber anchorage mechanism. Although no tissues 
were seeded to evaluate this method, the Background Research section outlines their capability 
in experiments conducted by Vandenburgh et al. Finally, he team achieved frequencies of strain 
between 0.2 and 0.6 Hz across the four trials. Although these frequency values lie largely outside 
of the stipulated 0.5-1.5Hz within the design specifications, the frequency of strain can be tuned 
via alteration of the Arduino code. 
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7.2.4 Compliance with Design Constraints 
The design constraints stated at the outset of project are as follows: 
1. Compatible with a standard culture plate 
a. 128x85x14mm 
2. Materials must be appropriate for use with live tissue constructs 
3. Budget 
a. $250/student; total budget of $750 
4. Timeline 
a. < 9 months 
As discussed throughout this report, a standard 96-well plate was used to fabricate a 
novel seeding system for the mechanical stimulation of engineered muscle. Because the first 
design constraint requested compatibility with a standard culture plate, a aluminum stand was 
machined according to the dimensions of a 96-well plate, therefore, the final design complied 
with that constraint. As discussed in section 7.2.2, the team selected prototyping materials such 
as the standard 96-well plate and PDMS layer, which are both known to be sterile/sterilizable 
and also pose no threat to cell viability.  
 The team encountered no issues regarding exceeding the maximum allowed budget for 
the project. A table outlining the project budget is presented in the Appendix section; Part D. 
In addition, while the presence of a < 9 month time constraint put pressure on the team to 
efficiently identify and execute the given problem within the revised client statement, the team 
still provided a sufficient proof-of-concept. 
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Chapter 8: Conclusions and Recommendations 
8.1 Conclusions 
In conclusion, the final proof-of-concept demonstrated by the team was successful in 
meeting the objectives, requirements and specifications as derived from the revised client 
statement. The final experiment proved the ability of the final design to yield a correlation 
between percent strain and z-displacement. The device exhibited the ability to apply theoretical 
tissue strains between 0 and 24%. Furthermore, variable experimental conditions can be achieved 
by alteration of the Arduino code; the frequency of stretching is tunable by the increasing the 
temporal delay between downward and upward movement, and the strain rate is tunable by 
altering the speed at which the motor operates. All of this can be done with the simple exchange 
of numbers within the Arduino code.  
8.2 Recommendations 
Due to time and resource constraints, at the termination of the project, the team noted 
several improvements which could be made. The first takeaway from the testing results and 
function of the device was improved precision, namely the accuracy of the jack component in 
addition to motor strength. A more level jack would directly correlate to more precise linear 
actuation and attribute to an overall more repeatable and reproducible procedure.  In addition, a 
stronger motor would allow actuation to occur more smoothly and without risk of wearing out 
the motor. The inclusion of electrical stimuli, in addition to the mechanical stimuli, would further 
improve the biomimetic properties of the engineered muscle tissues. If not for the time 
constraint, the group would have included both means of stimulation, knowing that in 
conjunction with each other, robust in-vitro muscle tissue can be generated. The next crucial 
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improvement would be waterproofing the electrical components of the design, if not the whole 
device, in order for compatibility with incubator conditions. This would make the system more 
efficient, while catering to maintenance of sterility.  
Improvements led the group to also consider recommendations in regard to future testing 
and work. The main recommendation is to perform further validation testing, mainly for 
consistency and abundance in the data collected. Important future work is actually seeding cells 
into the system the team designed and testing the maturation and function of the tissue constructs 
grown and conditioned. This can include the use of mouse and human muscle cells, as well as a 
mechanism to measure force production. These studies and the data collected will speak to the 
capabilities of the device created at engineering biomimetic muscle tissue. After the device is 
validated for this purpose it can then be considered for its intended use with drug screening 
technology.  
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Appendix 
A: Arduino Code 
The Arduino code to program the stepper motor was obtained from the Arduino library and 
adapted for the desired physical parameters. 
 
#include <Adafruit_MotorShield.h> 
#include <Wire.h> 
#include <Adafruit_MotorShield.h> 
#include "utility/Adafruit_MS_PWMServoDriver.h" 
  
// Create the motor shield object with the default I2C address 
Adafruit_MotorShield AFMS = Adafruit_MotorShield(); 
// Or, create it with a different I2C address (say for stacking) 
// Adafruit_MotorShield AFMS = Adafruit_MotorShield(0x61); 
  
// Connect a stepper motor with 200 steps per revolution (1.8 degree) 
// to motor port #2 (M3 and M4) 
Adafruit_StepperMotor *myMotor = AFMS.getStepper(200, 1); 
  
void setup() { 
  Serial.begin(9600);        // set up Serial library at 9600 bps 
  Serial.println("Stepper test!"); 
  
  AFMS.begin();  // create with the default frequency 1.6KHz 
  //AFMS.begin(1000);  // OR with a different frequency, say 1KHz 
  
  myMotor->setSpeed(40);  // 10 rpm   
} 
  
void loop() { 
  Serial.println("Single coil steps"); 
  myMotor->step(100, BACKWARD, SINGLE); 
  myMotor->step(100, FORWARD, SINGLE); 
  
delay(1000); 
  
  } 
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B: PDMS Protocol 
The protocol used for fabrication of the PDMS layer with incorporated PDMS inserts was taken from a 
database of WPI’s undergraduate Biomedical Engineering laboratories. 
 
Protocol for Making Polydimethylsiloxane (PDMS) 
Materials: 
·      Sylgard Silicone Elastomer base (Ellsworth Adhesive #184 SYL ELAST) 
·      Sylgard Silicone Elastomer curing agent (Ellsworth Adhesive #184 SYL ELAST) 
·      Gloves (The elastomer reagents are sticky and may be difficult to wash off) 
Procedure: 
1. Weigh 10 parts Sylgard silicone elastomer base and 1 part Sylgard silicone elastomer 
curing agent.  Note: DO NOT MIX THE STOCK SOLUTIONS!!!  Use separate weighing 
materials for each reagent. 
2. Pour reagents together and thoroughly mix the elastomer base and curing agent. 
3. Pour the well mixed solution into your mold. 
4. Degas the PDMS by putting it into a vacuum chamber for at least 1 hour (larger/thicker 
volumes of PDMS may require more time). 
5. After degassing, visually inspect the PDMS to ensure that there are no more bubbles.  If 
there are, repeat steps 4 and 5. 
6. Cure the PDMS by placing the mold into an oven set for 60 °C for at least 1 hour (larger 
samples may require more time). 
One important thing to keep in mind is that the uncured reagents are very tacky and can make a 
big mess of anything they contact (the degassing chamber, the scale used to weigh reagents).  
Students should wear gloves when handling PDMS, be careful not to spill, and make sure they 
clean up the space and equipment they use when preparing PDMS.   We keep “Goo Gone” in the 
lab for this reason… 
Students using PDMS will need access to the desiccating/vacuum chambers, a vacuum source, a 
scale (~ grams), weigh boats and an oven for curing.  
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C: Budget Analysis 
Table 8: Budget Analysis 
Item Date of Purchase Price Estimate Total Budget Left 
RoboGets Arduino 
Uno R3 Compatible 
Electronic 
ATmega328P 
Microcontroller Card 
& USB Cable                                                                                                                     
  
February 6, 2018 $17.90 $732.10 
Adafruit (PID 324) 
Stepper motor - 
NEMA-17 size - 200 
steps/rev, 12V 
350mA  
February 6, 2018 $25.62 $706.48 
Adafruit 
Motor/Stepper/Servo 
Shield for Arduino 
v2.3 Kit  
February 6, 2018 $21.18 $685.30 
Aluminum 6061 block  March 23, 2018 $70 $615.30 
96-well plates 
(bottomless) 
January 31, 2018 $136 $479.30 
Adherent, clamps March 17, 2018 $25 $454.30 
 
 
 
 
 
 
 
 
 
